FdaApplication
ANDA 205814
Identifiers
- fda_app_no: ANDA205814
Properties
| Property | Value |
|---|---|
| applicant_name | AUROLIFE PHARMA LLC |
| application_type | ANDA |
| approval_date | 2016-05-13 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HYDROMORPHONE HYDROCHLORIDE | HYDROMORPHONE HYDROCHLORIDE | 8MG | TABLET;ORAL |
| HYDROMORPHONE HYDROCHLORIDE | HYDROMORPHONE HYDROCHLORIDE | 4MG | TABLET;ORAL |
| HYDROMORPHONE HYDROCHLORIDE | HYDROMORPHONE HYDROCHLORIDE | 2MG | TABLET;ORAL |
3 products